Gentium SpA (NASDAQ:GENT)
| 8.49 Data as of 4:00pm ET |  -0.30 / -3.41%Today’s Change | 6.96 Today|||52-Week Range 12.84 | -25.20% Year-to-Date |
Latest GENT News | Press Releases
No recent news for Gentium SpA.
Today’s Trading
| Previous close | 8.79 |
| Today’s open | 8.61 |
| Day’s range | 8.47 - 8.70 |
| Volume | 8,566 |
| Average volume (3 months) | 28,222 |
| Market cap | $132.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -74.37% |
| Earnings growth (this year) | +837.94% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +17.30% |
| P/E ratio | NM |
| Price/Sales | 4.77 |
| Price/Book | 4.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENZNEnzon Pharmaceutical... | +0.09 | +2.93% |
| PTXPernix Therapeutics ... | +0.03 | +0.84% |
| APPAA.P. Pharma Inc | -0.02 | -3.41% |
| AVEOAveo Pharmaceuticals... | +0.04 | +1.50% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Last reporting date | May 16, 2013 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $35.7M |
| Annual profit (last year) | $999.8K |
| Net profit margin | 2.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Khalid Islam, PhD |
CFO, Senior VP & Head-Investor Relations Salvatore Calabrese |
Corporate headquarters Villa Guardia, Como |
Forecasts
